Cargando…
Pneumocystis jirovecii Pneumonia in a HIV-Infected Patient with a CD4 Count Greater Than 400 Cells/μL and Atovaquone Prophylaxis
We describe a rare case of Pneumocystis jirovecii pneumonia (PCP) in a heterosexual man with a pertinent medical history of well-controlled human immunodeficiency virus (HIV) on highly active antiretroviral therapy (HAART) and PCP prophylaxis with atovaquone. The patient presented with recurrent sho...
Autores principales: | Sullivan, Abigayle, Lanham, Theresa, Krol, Ronald, Zachariah, Shilla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374228/ https://www.ncbi.nlm.nih.gov/pubmed/32765916 http://dx.doi.org/10.1155/2020/8532780 |
Ejemplares similares
-
Comment on “Pneumocystis jirovecii Pneumonia in a HIV-Infected Patient with a CD4 Count Greater Than 400 Cells/μL and Atovaquone Prophylaxis”
por: Nevez, Gilles, et al.
Publicado: (2023) -
Nonadherence to Primary Prophylaxis against Pneumocystis jirovecii Pneumonia
por: Heffelfinger, James D., et al.
Publicado: (2009) -
1024. Evaluation of Atovaquone Prescribing for Pneumocystis jiroveci Pneumonia (PJP) Prophylaxis
por: Aleissa, Muneerah, et al.
Publicado: (2019) -
No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL
por: Atkinson, Andrew, et al.
Publicado: (2021) -
Discontinuation of Pneumocystis jirovecii Pneumonia Prophylaxis with CD4 Count <200 Cells/µL and Virologic Suppression: A Systematic Review
por: Costiniuk, Cecilia T., et al.
Publicado: (2011)